Primary HIV infection in infants: Impact of highly active antiretroviral therapy on the natural course

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

In the absence of any antiretroviral therapy, about one-third of infants with perinatally acquired HIV infection develop AIDS within the first months of life, while the remainder show slower disease progression. As the rate of viral replication during the first 3 months of life is strictly correlated with and predictive of disease outcome, any treatment that keeps the virus at low levels during primary infection might substantially modify the natural history of infection. Emerging data show that some infants treated early with highly active antiretroviral therapy have persistenty undetectable levels of HIV, and lack an HIV-specific immune response, despite preservation of immune functions. These findings strongly suggest that early therapeutic intervention might lead to a long-term suppression of viral replication.

Original languageEnglish
Pages (from-to)53-57
Number of pages5
JournalJournal of Biological Regulators and Homeostatic Agents
Volume16
Issue number1
Publication statusPublished - 2002

Fingerprint

Highly Active Antiretroviral Therapy
HIV infections
HIV Infections
HIV
virus replication
therapeutics
Infection
Disease Progression
Acquired Immunodeficiency Syndrome
Viruses
natural history
disease course
infection
Therapeutics
immune response
viruses

Keywords

  • Highly active antiretroviral therapy
  • HIV perinatal transmission
  • Primary infection

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Endocrinology
  • Physiology
  • Immunology
  • Medicine (miscellaneous)
  • Endocrinology, Diabetes and Metabolism
  • Physiology (medical)

Cite this

@article{bacce2fc8d72431e9ec19a4501f18041,
title = "Primary HIV infection in infants: Impact of highly active antiretroviral therapy on the natural course",
abstract = "In the absence of any antiretroviral therapy, about one-third of infants with perinatally acquired HIV infection develop AIDS within the first months of life, while the remainder show slower disease progression. As the rate of viral replication during the first 3 months of life is strictly correlated with and predictive of disease outcome, any treatment that keeps the virus at low levels during primary infection might substantially modify the natural history of infection. Emerging data show that some infants treated early with highly active antiretroviral therapy have persistenty undetectable levels of HIV, and lack an HIV-specific immune response, despite preservation of immune functions. These findings strongly suggest that early therapeutic intervention might lead to a long-term suppression of viral replication.",
keywords = "Highly active antiretroviral therapy, HIV perinatal transmission, Primary infection",
author = "{De Rossi}, A.",
year = "2002",
language = "English",
volume = "16",
pages = "53--57",
journal = "Journal of Biological Regulators and Homeostatic Agents",
issn = "0393-974X",
publisher = "Biolife s.a.s.",
number = "1",

}

TY - JOUR

T1 - Primary HIV infection in infants

T2 - Impact of highly active antiretroviral therapy on the natural course

AU - De Rossi, A.

PY - 2002

Y1 - 2002

N2 - In the absence of any antiretroviral therapy, about one-third of infants with perinatally acquired HIV infection develop AIDS within the first months of life, while the remainder show slower disease progression. As the rate of viral replication during the first 3 months of life is strictly correlated with and predictive of disease outcome, any treatment that keeps the virus at low levels during primary infection might substantially modify the natural history of infection. Emerging data show that some infants treated early with highly active antiretroviral therapy have persistenty undetectable levels of HIV, and lack an HIV-specific immune response, despite preservation of immune functions. These findings strongly suggest that early therapeutic intervention might lead to a long-term suppression of viral replication.

AB - In the absence of any antiretroviral therapy, about one-third of infants with perinatally acquired HIV infection develop AIDS within the first months of life, while the remainder show slower disease progression. As the rate of viral replication during the first 3 months of life is strictly correlated with and predictive of disease outcome, any treatment that keeps the virus at low levels during primary infection might substantially modify the natural history of infection. Emerging data show that some infants treated early with highly active antiretroviral therapy have persistenty undetectable levels of HIV, and lack an HIV-specific immune response, despite preservation of immune functions. These findings strongly suggest that early therapeutic intervention might lead to a long-term suppression of viral replication.

KW - Highly active antiretroviral therapy

KW - HIV perinatal transmission

KW - Primary infection

UR - http://www.scopus.com/inward/record.url?scp=0036255711&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036255711&partnerID=8YFLogxK

M3 - Article

C2 - 12003175

AN - SCOPUS:0036255711

VL - 16

SP - 53

EP - 57

JO - Journal of Biological Regulators and Homeostatic Agents

JF - Journal of Biological Regulators and Homeostatic Agents

SN - 0393-974X

IS - 1

ER -